James E. Radford

813 total citations
8 papers, 209 citations indexed

About

James E. Radford is a scholar working on Oncology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, James E. Radford has authored 8 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in James E. Radford's work include T-cell and B-cell Immunology (2 papers), Phytoestrogen effects and research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). James E. Radford is often cited by papers focused on T-cell and B-cell Immunology (2 papers), Phytoestrogen effects and research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). James E. Radford collaborates with scholars based in United States. James E. Radford's co-authors include Julia M. Cruz, David D. Hurd, James J. Vredenburgh, P. Nagesh Rao, Jeffrey S. Miller, Sergio Amadori, Elisabetta Abruzzese, Mark J. Pettenati, Gordon D. Ginder and Bo Wen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Thoracic Oncology.

In The Last Decade

James E. Radford

7 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Radford United States	6	90	84	67	42	36	8	209
Sharon Bergeron United States	8	57 0.6×	71 0.8×	152 2.3×	98 2.3×	27 0.8×	10	291
Rajni Agarwal‐Hashmi United States	5	76 0.8×	54 0.6×	44 0.7×	31 0.7×	15 0.4×	11	155
Valeria Calafiore Italy	7	149 1.7×	38 0.5×	62 0.9×	22 0.5×	14 0.4×	21	214
Morgani Rodrigues Brazil	9	123 1.4×	44 0.5×	51 0.8×	24 0.6×	19 0.5×	32	225
Yuki Arakawa Japan	7	37 0.4×	67 0.8×	23 0.3×	19 0.5×	29 0.8×	31	201
Lara Malerba Italy	11	131 1.5×	151 1.8×	47 0.7×	84 2.0×	19 0.5×	18	261
Sophie Dobbelstein France	6	168 1.9×	68 0.8×	37 0.6×	31 0.7×	40 1.1×	7	261
Pierangelo Spedini Italy	9	131 1.5×	54 0.6×	27 0.4×	82 2.0×	17 0.5×	16	271
Masae Matsumoto Japan	9	122 1.4×	84 1.0×	61 0.9×	6 0.1×	77 2.1×	16	308
M. Maynadié France	6	47 0.5×	60 0.7×	26 0.4×	131 3.1×	15 0.4×	6	236

Countries citing papers authored by James E. Radford

Since Specialization

Citations

This map shows the geographic impact of James E. Radford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Radford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Radford more than expected).

Fields of papers citing papers by James E. Radford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Radford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Radford. The network helps show where James E. Radford may publish in the future.

Co-authorship network of co-authors of James E. Radford

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Radford. A scholar is included among the top collaborators of James E. Radford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Radford. James E. Radford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Vitolins, Mara Z., Leah Griffin, Jacqueline Vuky, et al.. (2013). Randomized Trial to Assess the Impact of Venlafaxine and Soy Protein on Hot Flashes and Quality of Life in Men With Prostate Cancer. Journal of Clinical Oncology. 31(32). 4092–4098. 32 indexed citations

Griffin, Leah, Jacqueline Vuky, Paul T. Adams, et al.. (2011). Phase III randomized, double-blind, placebo-controlled trial of soy protein and venlafaxine for treatment of hot flashes in men with prostate cancer.. Journal of Clinical Oncology. 29(15_suppl). 9027–9027.

Miller, Antonius A., Xiaofei F. Wang, Jeffrey A. Bogart, et al.. (2007). Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002. Journal of Thoracic Oncology. 2(7). 645–651. 32 indexed citations

Kaya, Hakan, Yi‐Kong Keung, Douglas Case, et al.. (2002). Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 8(10). 544–549. 10 indexed citations

Abruzzese, Elisabetta, James E. Radford, Jeffrey S. Miller, et al.. (1999). Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation.. PubMed. 94(5). 1814–9. 66 indexed citations

Waring, Jeffrey F., James E. Radford, Linda J. Burns, & Gordon D. Ginder. (1995). The Human Leukocyte Antigen A2 Interferon-stimulated Response Element Consensus Sequence Binds a Nuclear Factor Required for Constitutive Expression. Journal of Biological Chemistry. 270(20). 12276–12285. 18 indexed citations

Radford, James E., et al.. (1993). Stimulation of MHC Class I Transcription by Interferon-γ Involves a Non-A, Non-C Kinase in Addition to Protein Kinase C. Journal of Interferon Research. 13(2). 133–141. 3 indexed citations

Radford, James E., C. Patrick Burns, Mary Jones, et al.. (1989). Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol.. Journal of Clinical Oncology. 7(1). 58–66. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact